University of Iowa Health Care News Release
June 9, 2003
UI Study Invites Participants With Type 2 Diabetes
People ages 21 to 78 with type 2 diabetes are invited to participate in a University of Iowa Health Care study on the effects of an investigational drug on blood fat (cholesterol) and blood sugar (glucose) levels.
Participation involves 13 visits over an 11-month period and several telephone interviews. Qualified participants will receive physical exams and electrocardiograms, blood and laboratory evaluations, nutrition and exercise counseling and a glucometer for home glucose monitoring. Compensation will be provided.
Participants randomly will be assigned to receive either one of two different doses of the investigational drug or a placebo (inactive substance). Glucose and cholesterol levels will be monitored, and other approved treatments will be added to the study treatment, if necessary.
For more information, call the UI Lipid Research Clinic at 319-384-5048 or toll-free at 800-887-6917.
University of Iowa Health Care describes the partnership between the UI Roy J. and Lucille A. Carver College of Medicine and UI Hospitals and Clinics and the patient care, medical education and research programs and services they provide. Visit UI Health Care online at www.uihealthcare.com.
STORY SOURCE: University of Iowa Health Science Relations, 5137 Westlawn, Iowa City, Iowa 52242-1178
MEDIA CONTACTS: Media: Becky Soglin (writer), 319-335-6660, firstname.lastname@example.org Study Participants: UI Lipid Research Clinic 319-384-5048 or toll-free 800-887-6917